COVID-19 remains a global crisis, particularly since we are moving into the more critical stage ("restart economy"), so please feel free to share this with anyone interested. Last evening, the world learned a Univ. of Chicago's Phase 3 trial of Gilead's (GILD) Remdesivir shows significant promise.
Remdesivir has been talked about for some time so I understand the skepticism, but the market has jumped 3% at the prospect.

Policymakers say a vaccine is key, but that could be six to 18 months away so the outlook for reopening the economy is grim if a vaccine is key. However, if COVID-19 spread is 10-20X greater than reported, then vaccines are less important than treatment. A vaccine means the entire US needs to be vaccinated and if 1% have side effects (just assumption, not a fact), then this could be worse arguably than catching COVID. On the other hand, a treatment means only those afflicted need to be dosed and this is more scalable and arguably safer. But take our observations with a grain of salt.

COVID-19 has caused the greatest economic contraction since the Great Depression, created considerable uncertainty and compressed news/economic/financial cycles from months to days. However, I have observed that control of financial markets has shifted to buyers (the "half ...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Want to receive Regular Market Updates to your Inbox?

I am your default error :)